Cases 51 - 60 of 178
CASE NUMBER NOT USED
as 1:2020cv01371
Defendant:
LEK PHARMACEUTICALS D.D., MACLEODS PHARMA USA, INC., APOTEX INC. and others
Plaintiff:
TAKEDA PHARMACEUTICALS INTERNATIONAL AG, H. LUNDBECK A/S, TAKEDA PHARMACEUTICALS U.S.A., INC. (TPUSA) and others
Interested Party:
ANITA H CLAYTON
In re: Entresto (Sacubitril/Valsartan) Patent Litigation
as 1:2020md02930
Counter Claimant:
Biocon Pharma Limited, Teva Pharmaceuticals USA, Inc., Alkem Laboratories Ltd. and others
Not Classified By Court:
Hetero USA Inc.,, Torrent Pharma Inc., Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Entresto (Sacubitril/Valsartan) Patent Litigation
Counter Defendant:
Novartis Pharmaceuticals Corporation
Defendant:
Noratech Labs, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Lupin Atlantis Holdings, S.A. et al
as 1:2020cv00415
Defendant:
Lupin Limited, Lupin Inc., Lupin Atlantis Holdings, S.A., Lupin Pharmaceuticals, Inc. and others
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
MERCK SHARP & DOHME B.V. et al v. LUPIN LIMITED et al
as 2:2020cv02786
Defendant:
LUPIN LIMITED, LUPIN PHARMACEUTICALS, INC. and LUPIN INC.
Plaintiff:
MERCK SHARP & DOHME B.V, ORGANON USA INC. and MERCK SHARP & DOHME B.V.
Cause Of Action: 35 U.S.C. § 271
ViiV Healthcare Company et al v. Lupin Limited et al
as 1:2020cv00293
Plaintiff:
ViiV Healthcare UK (No. 3) Limited, Shionogi & Co., Ltd. and ViiV Healthcare Company
Defendant:
Lupin Limited and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Gilead Sciences, Inc. v. Apotex, Inc. et al
as 1:2020cv00189
Defendant:
Macleods Pharmaceuticals Ltd., Cipla Limited, Apotex, Inc. and others
Plaintiff:
Gilead Sciences, Inc.
Cause Of Action: 35 U.S.C. § 1
CyDex Pharmaceuticals, Inc. v. Lupin Limited et al
as 1:2019cv02043
Defendant:
Lupin Pharmaceuticals, Inc. and Lupin Limited
Plaintiff:
CyDex Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Otsuka Pharmaceutical Co., Ltd. et al v. Lupin Limited et al
as 1:2019cv01988
Defendant:
Lupin Pharmaceuticals, Inc. and Lupin Limited
Plaintiff:
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Alkem Laboratories Ltd. et al
as 1:2019cv01979
Defendant:
Teva Pharmaceuticals USA, Inc., Aurobindo Pharma USA Inc., Lupin Inc. and others
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
as 1:2019md02902
Counter Defendant:
Merck Sharp & Dohme Corp.
Not Classified By Court:
Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Limited and others
Counter Claimant:
Macleods Pharmaceuticals Limited
In Re:
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
Defendant:
Accord Healthcare, Inc., Teva Pharmaceutical Industries Ltd., Inventia Healthcare Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
